MaxCyte Appoints Experienced Agilent Veteran Parmeet Ahuja as New CFO

summarizeSummary

MaxCyte appointed Parmeet Ahuja, an experienced finance leader from Agilent Technologies, as its new CFO, a positive move amidst recent financial and compliance challenges.

check_boxKey Events

• New Chief Financial Officer Appointed

  Parmeet Ahuja has been appointed as MaxCyte's Chief Financial Officer, effective March 30, 2026. He succeeds Douglas Swirsky, whose transition was previously announced in November 2025.

• Experienced Finance Leader Joins

  Mr. Ahuja brings over 20 years of finance leadership experience from Agilent Technologies, a global life sciences organization, including roles in investor relations and financial planning and analysis.

• Compensation Package Detailed

  Mr. Ahuja will receive an annual base salary of $450,000, an initial target bonus of 50% of his base salary, and equity awards consisting of 375,000 stock options and 187,500 restricted stock units.

auto_awesomeAnalysis

MaxCyte, which recently disclosed significant financial challenges, a workforce reduction, and a Nasdaq non-compliance notice, has appointed Parmeet Ahuja as its new Chief Financial Officer. Mr. Ahuja brings over two decades of finance leadership experience from Agilent Technologies, a publicly traded life sciences company. This appointment is a positive development, signaling the company's commitment to strengthening its financial operations and strategic leadership during a critical period, following a series of negative disclosures.